“…In addition, the Tesla-like microchannel can mimic the physiological shear rates in blood flows, providing a more faithful platform for analyzing the coagulopathy. Notably, the conventional flow driver in microfluidic viscometers, typically a peristaltic pump, is both cost-intensive, and space-, blood-consuming, showing difficulty in the point-of-care testing ( Leach et al, 2003 ; Xie et al, 2004 ; Collins et al, 2016 ; Davis et al, 2021 ). Thus, a miniaturized and user-friendly platform is supposed to be developed for the microfluidic pumping in the clinic.…”